Cambridge biotech Summit pivots from failed trial, layoffs with $4.5M from CARB-X

CARB-X's $4.5 million award comes just a few weeks after the company shut down on a Duchenne muscular dystrophy trial and laid off most of their employees in Cambridge.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news